A new type of antibody test is being developed by researchers at Linnaeus University and the bioanalysis company Attana. Compared to the binary antibody tests used today, this rapid test can give more detailed information on how our immune systems react to covid-19 and other types of viruses and bacteria.
The research groups, led by Ian Nicholls and Per Nilsson at Linnaeus University and Teodor Aastrup at Attana, are currently developing and evaluating a new diagnostic platform with the name AVA (Attana Virus Analytics). Tests have been conducted through serum, plasma, and full blood analyses to study individuals’ immune response to SARS Cov-2 and the bacteria Clostridium tetani, which causes tetanus. The samples have been collected from both the bend of the arm and from finger sticks with promising results, which enables easy sampling where results can be ready in 15 minutes.
That sounds really good 2greys. You seem very knowledgeable.I am wondering if the Oxford zeneca vaccine would work for me. I have Bronchiectasis but over the last 9 years my immunoglobulins have decreased a lot. Igg & iga are still in the normal range but igm is well below. Does this constitute immune deficiency? My husband says not but I don't know.
I am keen to get vaccinated asap but would like to think it would be effective against covid.
The immune system operates on many different levels, so in my opinion your husband is correct. Out of choice of the vaccines, it has been suggested that the AstraZeneca vaccine is better in promoting T-cell immunity, this would be my choice if given the chance. Given the availability of vaccines, it is more likely that the AstraZeneca will be offered.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.